| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Michael Andrew Chambers is Director at SRPT. Michael Andrew Chambers's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $510K at current prices.
Our model assigns Michael Andrew Chambers a middling insider score of 56/100, based on 6 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of -2.6%.
Net of sales, the SRPT filings show accumulation of 208,840 shares.
Michael Andrew Chambers has 13 Form 4 filings on record from June 2022 to June 2026, all as Director at Sarepta Therapeutics (SRPT), 2022–2026.
The 26 reported transactions were 14 open-market purchases, 6 option or other derivative awards, 5 stock awards and 1 disposition back to the company.
Counted by filing, the open-market trades come to 6 purchases worth about $23.3M and no sales.
The largest open-market purchase was 57,100 shares of SRPT at an average $104.43 on September 14, 2022, about $6.0M. Twelve months later SRPT was up 11%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 37,038 | $133.80 | $4,955,728.14 | +15.0% | -18.2% | -83.7% | |
| Aug 14, 2023 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 9,979 | $109.47 | $1,092,429.41 | +4.2% | -29.1% | +18.7% | |
| Aug 11, 2023 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 23,686 | $108.05 | $2,559,272.30 | +11.1% | -26.7% | +16.0% | |
| Aug 10, 2023 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 34,867 | $106.15 | $3,701,067.12 | +19.5% | -23.9% | +18.2% | |
| Sep 14, 2022 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 57,100 | $104.43 | $5,963,124.30 | +111.8% | +14.2% | +11.3% | |
| Aug 19, 2022 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 46,170 | $108.28 | $4,999,230.00 | +940.7% | +1.9% | +3.7% |